Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention

JAMA

Volumn 309, Issue 19, 2013, Pages 2025-2034

  Peterson, Pamela N ^a,b,d   Varosy, Paul D ^b,d,e   Heidenreich, Paul A ^f   Wang, Yongfei ^g   Dewland, Thomas A ^h   Curtis, Jeptha P ^g   Go, Alan S ^h,i,j   Greenlee, Robert T ^k   Magid, David J ^b,c,d   Normand, Sharon Lise T ^l,m   Masoudi, Frederick A ^d  

^a DENVER HEALTH MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d KAISER PERMANENTE   (United States)

^e VA Eastern Colorado Health Care System   (United States)

^f VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^g YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ DIVISION OF RESEARCH   (United States)

^j STANFORD UNIVERSITY   (United States)

^k MARSHFIELD CLINIC   (United States)

^l HARVARD MEDICAL SCHOOL   (United States)

^m HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AGED; ARTICLE; BLOOD TRANSFUSION; COHORT ANALYSIS; CONTROLLED STUDY; DUAL CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; EQUIPMENT FAILURE; FEMALE; FIRST DEGREE ATRIOVENTRICULAR BLOCK; HEART DEATH; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE TACHYCARDIA; HEMATOMA; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PNEUMOTHORAX; POSTOPERATIVE COMPLICATION; PRIMARY PREVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGLE CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; SUDDEN CARDIAC DEATH; TREATMENT INDICATION;

EID: 84877787625     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.4982     Document Type: Article

References (30)

1. Centers for Medicare & Medicaid Services. NCD for implantable automatic defibrillators (20.4). http://www.cms.gov/medicare-coverage-database/ details/ncd-details.aspx?NCDId=110&ncdver=3&IsPopup=y&NCAId= 102&NcaName=Implantable+Defibrillators+-+Clinical+Trials&bc= AAAAAAAAIAAA&m. Accessed April 20, 2013.
2. Epstein AE, DiMarco JP, Ellenbogen KA, et al American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008;117(21):e350-e408.
3. Dewland TA, Pellegrini CN, Wang Y, Marcus GM, Keung E, Varosy PD. Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry. J Am Coll Cardiol. 2011;58(10):1007-1013.
4. Matlock DD, Peterson PN, Wang Y, et al. Variation in use of dual-chamber implantable cardioverter-defibrillators: results from the national cardiovascular data registry. Arch Intern Med. 2012;172(8):634-641.
5. McClellan MB, Tunis SR.Medicare coverage of ICDs. N Engl J Med. 2005;352(3):222-224. (Pubitemid 40110810)
6. Hammill SC, Kremers MS, Stevenson LW, et al. Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure. Heart Rhythm. 2010;7(9):1340-1345.
7. Hammill SC, Stevenson LW, Kadish AH, et al. Review of the registry's first year, data collected, and future plans. Heart Rhythm. 2007;4(9):1260-1263. (Pubitemid 47324135)
8. Messenger JC, Ho KK, Young CH, et al NCDR Science and Quality Oversight Committee Data Quality Workgroup. The National Cardiovascular Data Registry (NCDR) Data Quality Brief: the NCDR Data Quality Program in 2012. J Am Coll Cardiol. 2012;60(16):1484-1488.
9. Brennan JM, Peterson ED, Messenger JC, et al; Duke Clinical Research Institute DEcIDE Team. Linking the National Cardiovascular Data Registry CathPCI Registry with Medicare claims data: validation of a longitudinal cohort of elderly patients undergoing cardiac catheterization. Circ Cardiovasc Qual Outcomes. 2012;5(1):134-140.
10. National Quality Forum. National Voluntary Consensus Standards for Patient Outcomes: A Consensus Report. Washington, DC: National Quality Forum; 2011:A1-A6.
11. Gu XS, Rosenbaum PR. Comparison of multivariate matching methods: structures, distances, and algorithms. J Comput Graph Statist. 1993;2:405-420.
12. Cohen J. The t test for means. In: Cohen J, ed. Statistial Power Analysis for the Behavioral Sciences. Toronto, ON: Academic Press Inc; 1977.
13. Wilkoff BL, Kudenchuk PJ, Buxton AE, et al; DAVID II Investigators. The DAVID (Dual Chamber and VVI Implantable Defibrillator) II trial. J Am Coll Cardiol. 2009;53(10):872-880.
14. Olshansky B, Day JD, Moore S, et al. Is dualchamber programming inferior to single-chamber programming in an implantable cardioverterdefibrillator? results of the INTRINSIC RV (Inhibition of Unnecessary RV Pacing With AVSH in ICDs) study. Circulation. 2007;115(1):9-16. (Pubitemid 46058606)
15. Al-Khatib SM, Greiner MA, Peterson ED, Hernandez AF, Schulman KA, Curtis LH. Patient and implanting physician factors associated with mortality and complications after implantable cardioverter-defibrillator implantation, 2002-2005. Circ Arrhythm Electrophysiol. 2008;1(4):240-249.
16. Reynolds MR, Cohen DJ, Kugelmass AD, et al. The frequency and incremental cost of major complications among Medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol. 2006;47(12):2493-2497. (Pubitemid 43866387)
17. Mark DB, Nelson CL, Anstrom KJ, et al SCDHeFT Investigators. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation. 2006;114(2):135-142. (Pubitemid 44420745)
18. Sanders GD, Hlatky MA, Owens DK. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med. 2005;353(14):1471-1480. (Pubitemid 41400921)
19. Goldberger Z, Elbel B, McPherson CA, Paltiel AD, Lampert R. Cost advantage of dual-chamber versus single-chamber cardioverter-defibrillator implantation. J Am Coll Cardiol. 2005;46(5):850-857. (Pubitemid 41224810)
20. Thijssen J, Borleffs CJW, van Rees JB, et al. Implantable cardioverter-defibrillator longevity under clinical circumstances: an analysis according to device type, generation, and manufacturer. Heart Rhythm. 2012;9(4):513-519.
21. Russo AM. The reality of implantable cardioverter-defibrillator longevity: what can be done to improve cost-effectiveness? Heart Rhythm. 2012;9(4):520-521.
22. Matlock DD, Peterson PN, Wang Y, et al. Variation in use of dual-chamber implantable cardioverter-defibrillators: results from the national cardiovascular data registry. Arch Intern Med. 2012;172(8):634-641.
23. Dorian P, Philippon F, Thibault B, et al ASTRID Investigators. Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter- defibrillator. Heart Rhythm. 2004;1(5):540-547. (Pubitemid 39462711)
24. Almendral J, Arribas F, Wolpert C, et al DATAS Steering Committee; DATAS Writing Committee; DATAS Investigators. Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial. Europace. 2008;10(5):528-535. (Pubitemid 351775295)
25. Theuns DAMJ, Klootwijk AP, Goedhart DM, Jordaens LJLM. Prevention of inappropriate therapy in implantable cardioverter-defibrillators: results of a prospective, randomized study of tachyarrhythmia detection algorithms. J Am Coll Cardiol. 2004;44(12):2362-2367. (Pubitemid 39647611)
26. Deisenhofer I, Kolb C, Ndrepepa G, et al. Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study. J Cardiovasc Electrophysiol. 2001;12(2):134-142. (Pubitemid 32171500)
27. Friedman PA, McClelland RL, Bamlet WR, et al. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study. Circulation. 2006;113(25):2871-2879. (Pubitemid 44297227)
28. Moss AJ, Schuger C, Beck CA, et al. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012;367(24):2275-2283.
29. Wilkoff BL, Cook JR, Epstein AE, et al Dual Chamber and VVI Implantable Defibrillator Trial Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA. 2002;288(24):3115-3123. (Pubitemid 36014128)
30. Sweeney MO, Ellenbogen KA, Tang ASL, et al Managed Ventricular Pacing Versus VVI 40 Pacing Trial Investigators. Atrial pacing or ventricular backup-only pacing in implantable cardioverter-defibrillator patients. Heart Rhythm. 2010;7(11):1552-1560.